Edesa Biotech, Inc. Common Shares (EDSA) is a publicly traded Healthcare sector company. As of July 26, 2026, EDSA trades at $5.45 with a market cap of $50.57M and a P/E ratio of -4.29. EDSA moved -4.42% today. Year to date, EDSA is +269.72%; over the trailing twelve months it is +118.75%. Its 52-week range spans $0.72 to $20.32. Analyst consensus is buy with an average price target of $21.00. Rallies surfaces EDSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for EDSA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.45 |
| Market Cap | $50.57M |
| P/E Ratio | -4.29 |
| EPS | $-1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.32 |
| 52-Week Low | $0.72 |
| Volume | 45.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.19M |
| Gross Margin | 0.00% |
1 analysts cover EDSA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.00.